Total Payments
$57,489
2024 Payments
$44,483
Companies
33
Transactions
158
Medicare Patients
3,975
Medicare Billing
$290,153
Payment Breakdown by Category
Other$29,220 (50.8%)
Consulting$17,286 (30.1%)
Food & Beverage$6,865 (11.9%)
Travel$4,118 (7.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,286 | 7 | 30.1% |
| Long term medical supply or device loan | $15,300 | 1 | 26.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,810 | 3 | 22.3% |
| Food and Beverage | $6,865 | 135 | 11.9% |
| Travel and Lodging | $4,118 | 10 | 7.2% |
| Honoraria | $1,110 | 1 | 1.9% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$57,489
157 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15,329 | 13 | $0 (2024) |
| Central Indiana URS Consumables, LLC | $15,300 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $11,577 | 16 | $0 (2024) |
| PFIZER INC. | $5,009 | 12 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,129 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $2,672 | 29 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $733.31 | 12 | $0 (2024) |
| Agiliti Surgical, Inc. | $425.40 | 6 | $0 (2024) |
| GENZYME CORPORATION | $317.52 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $279.03 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,483 | 83 | Central Indiana URS Consumables, LLC ($15,300) |
| 2023 | $10,303 | 48 | Bayer Healthcare Pharmaceuticals Inc. ($7,535) |
| 2022 | $2,703 | 27 | PFIZER INC. ($1,294) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 12/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/26/2024 | Central Indiana URS Consumables, LLC | Dornier MedTech (Medical Supply), CVAC Aspiration System, Dornier MedTech | Long term medical supply or device loan | Stock option | $15,300.00 | General |
| Category: Ureteroscopy | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $144.10 | General |
| Category: Oncology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 11/13/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 11/13/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 11/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $59.81 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $92.41 | General |
| 11/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $1,690.70 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $102.97 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,316 | 4,281 | $587,587 | $147,683 |
| 2022 | 28 | 1,545 | 1,842 | $358,963 | $85,172 |
| 2021 | 33 | 1,058 | 1,349 | $205,346 | $50,617 |
| 2020 | 4 | 56 | 62 | $30,082 | $6,681 |
Total Patients
3,975
Total Services
7,534
Medicare Billing
$290,153
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 2,520 | $75,600 | $47,061 | 62.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 280 | $71,960 | $25,262 | 35.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 141 | $99,264 | $18,277 | 18.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 48 | 80 | $62,240 | $13,667 | 22.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 40 | $19,640 | $5,177 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 81 | $14,094 | $5,013 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 39 | $13,533 | $4,977 | 36.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 75 | $13,125 | $4,276 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $13,350 | $3,557 | 26.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 27 | 30 | $61,875 | $2,642 | 4.3% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 11 | 11 | $32,550 | $2,461 | 7.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 112 | 115 | $8,740 | $2,046 | 23.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,296 | $1,493 | 28.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $51,100 | $1,198 | 2.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 27 | 32 | $6,560 | $1,088 | 16.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 12 | $3,024 | $1,065 | 35.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 11 | 11 | $5,159 | $1,033 | 20.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 27 | 42 | $3,822 | $1,017 | 26.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 22 | $2,112 | $809.38 | 38.3% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 33 | 41 | $2,483 | $736.80 | 29.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 27 | 28 | $2,968 | $708.12 | 23.9% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 83 | 87 | $2,871 | $688.17 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 69 | $683.00 | $566.47 | 82.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 138 | 218 | $2,180 | $478.30 | 21.9% |
| 87088 | Bacterial urine culture | Office | 2023 | 50 | 59 | $2,006 | $467.87 | 23.3% |
About Dr. Eugene Cone, M.D
Dr. Eugene Cone, M.D is a Urology healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083955538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Cone, M.D has received a total of $57,489 in payments from pharmaceutical and medical device companies, with $44,483 received in 2024. These payments were reported across 158 transactions from 33 companies. The most common payment nature is "Consulting Fee" ($17,286).
As a Medicare-enrolled provider, Cone has provided services to 3,975 Medicare beneficiaries, totaling 7,534 services with total Medicare billing of $290,153. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Greenwood, IN
- Active Since 03/08/2013
- Last Updated 01/19/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1083955538
Products in Payments
- Dornier MedTech (Medical Supply) $15,300
- KEYTRUDA (Biological) $14,947
- Nubeqa (Drug) $11,457
- ERLEADA (Drug) $1,885
- TALZENNA (Drug) $1,110
- PROVENGE (Drug) $733.31
- Sonablate (Device) $346.00
- JEVTANA (Drug) $317.52
- Xtandi (Drug) $224.17
- ANKTIVA (Drug) $176.71
- PYLARIFY (Drug) $153.67
- XTANDI (Drug) $144.72
- LYNPARZA (Drug) $144.03
- ADSTILADRIN (Drug) $142.54
- Xofigo (Drug) $120.82
- JELMYTO (Drug) $105.30
- Da Vinci Surgical System (Device) $98.86
- PLUVICTO (Drug) $83.87
- AQUABEAM SYSTEM (Device) $82.56
- Sonablate HIFU (Device) $79.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Greenwood
Bradley Orris, M.d, M.D
Urology — Payments: $27,697
Urology $27,697
David Gilley, Md, MD
Urology — Payments: $23,775
Urology $23,775
Brian Orr, Md, MD
Urology — Payments: $22,029
Urology $22,029
Dr. Charles Schwab, Md, MD
Urology — Payments: $16,903
Urology $16,903
Dr. Todd Hansen, M.d, M.D
Urology — Payments: $5,652
Urology $5,652
Herman Parramore, M.d, M.D
Urology — Payments: $5,576
Urology $5,576